Comparing two medicines for feeding tube intolerance in ICU patients
Treatments studied
Part of Digestive system clinical trials.
This trial compares two medicines, mosapride and metoclopramide, to see which one better helps patients in the intensive care unit (ICU) who have trouble digesting food given through a feeding tube. Both medicines are prokinetics, which help the stomach move food along.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You are in the intensive care unit (ICU) and expected to stay for at least 7 days.
- You are receiving food through a feeding tube.
- You have not had stomach or intestinal surgery, a blockage, or bleeding, and you do not have a stomach or intestinal disease.
- You have not used certain medicines (like acid reducers or prokinetics) in the past 4 weeks.
- You do not have liver problems, heart rhythm problems, diabetes, or a head injury.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of giving liquid food through a tube into the stomach for people in the intensive care unit. It looks at whether continuous feeding is better than intermittent feeding in terms of how much food remains in the stomach, which can affect digestion and safety.
This study looks at whether giving tube feeding formula in a diluted or undiluted form is better for people who are in the intensive care unit (ICU) after major abdominal surgery. The goal is to find out which method is more effective and helps recovery.
This study compares two medications that help empty the stomach faster (itopride and metoclopramide) to see which works better for hospital patients with a high amount of leftover stomach contents while on tube feeding. If you qualify, you may receive one of these medications to help with digestion.
This study looks at how critically ill patients on a breathing tube and receiving nutrition through a tube tolerate their feeding, depending on the dose of medications given to manage their blood pressure. It aims to see if feeding works well while patients are on these medications.
This study looks at whether certain biomarkers and stomach motility measurements can help predict feeding intolerance in critically ill patients who cannot eat by mouth. It aims to improve how patients are fed in the ICU.
This trial tests an injectable medicine, mosapride citrate, to help the gut start working again after laparoscopic intestinal surgery. It may reduce bloating, pain, and time to first bowel movement.
Hear when a new Enteral Feeding Intolerance trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.